T&L Co., Ltd. (KOSDAQ:340570)

South Korea flag South Korea · Delayed Price · Currency is KRW
78,600
+100 (0.13%)
At close: Mar 27, 2025, 3:30 PM KST
50.86%
Market Cap 619.93B
Revenue (ttm) 174.89B
Net Income (ttm) 46.41B
Shares Out 8.07M
EPS (ttm) 5,749.19
PE Ratio 13.36
Forward PE 9.95
Dividend 750.00 (0.98%)
Ex-Dividend Date Dec 27, 2024
Volume 45,739
Average Volume 72,050
Open 77,600
Previous Close 78,500
Day's Range 77,000 - 79,800
52-Week Range 50,400 - 85,600
Beta 0.28
RSI 46.56
Earnings Date Mar 17, 2025

About T&L Co., Ltd.

T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was founded in 1998 and is headquartered in Yongin-si, South Korea. [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 1998
Employees 142
Stock Exchange KOSDAQ
Ticker Symbol 340570
Full Company Profile

Financial Performance

In 2024, T&L Co., Ltd.'s revenue was 174.89 billion, an increase of 51.47% compared to the previous year's 115.46 billion. Earnings were 46.41 billion, an increase of 69.13%.

Financial Statements

News

There is no news available yet.